Protean Small Cap returned -2.3% in November, underperforming its index by 1.3% points. Year to date, the fund’s return is 15 ...
Insmed Incorporated (Nasdaq: INSM), a people-first global biopharmaceutical company striving to deliver first- and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback